Related references
Note: Only part of the references are listed.Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma Report from the German Craniopharyngioma Registry
Klaus Christian Mende et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses
Joshua D. Wallach et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics
Jessica R. Gooding et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Proteomics
Shipra Agrawal et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Jonatan Barrera-Chimal et al.
KIDNEY INTERNATIONAL (2019)
Vitamin D and health - The missing vitamin in humans
Szu-Wen Chang et al.
PEDIATRICS AND NEONATOLOGY (2019)
Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes A Randomized Clinical Trial
Ian H. de Boer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Molecular stratification of idiopathic nephrotic syndrome
Moin A. Saleem
NATURE REVIEWS NEPHROLOGY (2019)
Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease
Akira Nishiyama
HYPERTENSION RESEARCH (2019)
Recurrent activating mutations of PPARγ associated with luminal bladder tumors
Natacha Rochel et al.
NATURE COMMUNICATIONS (2019)
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Xiaoxin X. Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Glucocorticoids in the Treatment of Glomerular Diseases Pitfalls and Pearls
Claudio Ponticelli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
Juan Jesus Carrero et al.
NATURE REVIEWS NEPHROLOGY (2018)
Mineralocorticoid Receptor and Cardiovascular Disease
Mathieu Buonafine et al.
AMERICAN JOURNAL OF HYPERTENSION (2018)
Podocyte-Specific Induction of Kruppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease
Yiqing Guo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
PPARγΔ5, a Naturally Occurring Dominant-Negative Splice Isoform, Impairs PPARγ Function and Adipocyte Differentiation
Marianna Aprile et al.
CELL REPORTS (2018)
Investigations of Glucocorticoid Action in GN
Christoph Kuppe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition
Ramon Sonneveld et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Kruppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers
Sandeep K. Mallipattu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Vitamin D receptor deficit induces activation of renin angiotensin system via SIRT1 modulation in podocytes
Nirupama Chandel et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2017)
Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α
Yan Dai et al.
KIDNEY INTERNATIONAL (2017)
Glucocorticoid receptor control of transcription: precision and plasticity via allostery
Emily R. Weikum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system
Barbara Toffoli et al.
PLOS ONE (2017)
A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy
Clarice K. Fujihara et al.
SCIENTIFIC REPORTS (2017)
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation
Angela M. Halstead et al.
ELIFE (2017)
VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway
Jia Guo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Adverse effects of isotretinoin: A large, retrospective review
Piotr Brzezinski et al.
DERMATOLOGIC THERAPY (2017)
Steroid-resistant nephrotic syndrome: past and current perspectives
Noureddin Nourbakhsh et al.
PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS (2017)
Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy
Nina Cabezas-Wallscheid et al.
CELL (2017)
Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus
Lawrence H. Young et al.
CIRCULATION (2017)
A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome
Michael R. Bennett et al.
BIOMARKER INSIGHTS (2017)
Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis
S. E. Trasino et al.
DIABETES OBESITY & METABOLISM (2016)
Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN
Carole Henique et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Topical Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged Skin
Ryan R. Riahi et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2016)
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
W. N. Kernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Retinoids and rexinoids in cancer prevention: from laboratory to clinic
Ivan P. Uray et al.
SEMINARS IN ONCOLOGY (2016)
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Gemma Currie et al.
BMC NEPHROLOGY (2016)
Vitamin D and its receptor regulate lipopolysaccharide-induced transforming growth factor-β, angiotensinogen expression and podocytes apoptosis through the nuclear factor-κB pathway
Lijuan Xu et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Specificity and sensitivity of glucocorticoid signaling in health and disease
Derek W. Cain et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
All-trans-retinoic Acid Reduces BACE1 Expression under Inflammatory Conditions via Modulation of Nuclear Factor κB (NFκB) Signaling
Ruishan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Epigenetic Modulation of Human Podocyte Vitamin D Receptor in HIV Milieu
Nirupama Chandel et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte
Marjolein Garsen et al.
JOURNAL OF PATHOLOGY (2015)
Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes
Barbara Lewko et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Inhibition of microRNA-30a prevents puromycin aminonucleoside-induced podocytic apoptosis by upregulating the glucocorticoid receptor α
Hua Xie et al.
MOLECULAR MEDICINE REPORTS (2015)
Pharmacological repression of PPARγ promotes osteogenesis
David P. Marciano et al.
NATURE COMMUNICATIONS (2015)
The evidence-based approach to adult-onset idiopathic nephrotic syndrome
Pietro A. A. Canetta et al.
FRONTIERS IN PEDIATRICS (2015)
The beneficial role of retinoids in glomerular disease
Sandeep K. Mallipattu et al.
FRONTIERS IN MEDICINE (2015)
Retinoid treatment of skin diseases
Lisa Beckenbach et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2015)
25-Hydroxyvitamin D Testing and Supplementation in CKD: An NKF-KDOQI Controversies Report
Holly Kramer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
GSK-3β and Vitamin D Receptor are Involved in β-Catenin and Snail Signaling in High Glucose-Induced Epithelial-Mesenchymal Transition of Mouse Podocytes
Jia Guo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Downregulation of MicroRNA-30 Facilitates Podocyte Injury and Is Prevented by Glucocorticoids
Junnan Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Albumin-induced podocyte injury and protection are associated with regulation of COX-2
Shipra Agrawal et al.
KIDNEY INTERNATIONAL (2014)
A dynamic CTCF chromatin binding landscape promotes DNA hydroxymethylation and transcriptional induction of adipocyte differentiation
Julie Dubois-Chevalier et al.
NUCLEIC ACIDS RESEARCH (2014)
Interconnected Network Motifs Control Podocyte Morphology and Kidney Function
Evren U. Azeloglu et al.
SCIENCE SIGNALING (2014)
Retinoids and Glomerular Regeneration
Elena Lazzeri et al.
SEMINARS IN NEPHROLOGY (2014)
PPARγ and the global map of adipogenesis and beyond
Martina I. Lefterova et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Molecular Architecture of Transcription Factor Hotspots in Early Adipogenesis
Rasmus Siersbaek et al.
CELL REPORTS (2014)
Vitamin D Down-Regulates TRPC6 Expression in Podocyte Injury and Proteinuric Glomerular Disease
Ramon Sonneveld et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Aldosterone mediates glomerular inflammation in experimental mesangial proliferative glomerulonephritis
Danping Qin et al.
JOURNAL OF NEPHROLOGY (2013)
Proteinuria Impairs Podocyte Regeneration by Sequestering Retinoic Acid
Anna Peired et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Active Vitamin D Treatment for Reduction of Residual Proteinuria: A Systematic Review
Martin H. de Borst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Adiponectin Promotes Functional Recovery after Podocyte Ablation
Joseph M. Rutkowski et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease-chronic kidney disease-mineral and bone disorder: Osteoporosis
Wen-Ling Lee et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2013)
PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation
Yuji Ishibashi et al.
MICROVASCULAR RESEARCH (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Vitamin D Receptor Signaling in Renal and Cardiovascular Protection
Yan Chun Li
SEMINARS IN NEPHROLOGY (2013)
The effect of vitamin D on insulin resistance in patients with type 2 diabetes
Afsaneh Talaei et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
Nuclear Receptors and Their Selective Pharmacologic Modulators
Thomas P. Burris et al.
PHARMACOLOGICAL REVIEWS (2013)
Protective effects of peroxisome proliferator-activated receptor agonists on human podocytes: proposed mechanisms of action
Gianluca Miglio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy
Jun Ling et al.
CANCER LETTERS (2012)
Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease
Michal L. Melamed et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases
Jichun Yang et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
Kruppel-like Factor 15 (KLF15) Is a Key Regulator of Podocyte Differentiation
Sandeep K. Mallipattu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Vitamin D Receptor Signaling in Podocytes Protects against Diabetic Nephropathy
Youli Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
Ronac Mamtani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Protective effects of PPAR gamma agonist in acute nephrotic syndrome
Yiqin Zuo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Peroxisome proliferator-activated receptor- activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in Type 2 diabetes
Eun Young Lee et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Retinoids Augment the Expression of Podocyte Proteins by Glomerular Parietal Epithelial Cells in Experimental Glomerular Disease
Jiong Zhang et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2012)
Vitamin D Receptor Activators Upregulate and Rescue Podocalyxin Expression in High Glucose-Treated Human Podocytes
S. N. Verouti et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2012)
Nuclear hormone receptors in podocytes
Simran Khurana et al.
CELL AND BIOSCIENCE (2012)
Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis
Nobuaki Takagi et al.
NEPHRON EXTRA (2012)
Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte Damage A Therapeutic Target of PPARγ
Chunhua Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury
Gianluca Miglio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Dexamethasone increases the phosphorylation of nephrin in cultured podocytes
Teiko Ohashi et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
Eva Moran-Salvador et al.
FASEB JOURNAL (2011)
Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway
Shigeru Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Blockade of Wnt/beta-Catenin Signaling by Paricalcitol Ameliorates Proteinuria and Kidney Injury
Weichun He et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice
Sophie Doublier et al.
KIDNEY INTERNATIONAL (2011)
Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis
Michal L. Melamed et al.
KIDNEY INTERNATIONAL (2011)
Role of the retinoic acid receptor-α in HIV-associated nephropathy
Krishna K. Ratnam et al.
KIDNEY INTERNATIONAL (2011)
Comparison of Direct Action of Thiazolidinediones and Glucocorticoids on Renal Podocytes: Protection from Injury and Molecular Effects
Shipra Agrawal et al.
MOLECULAR PHARMACOLOGY (2011)
Effect of Synthetic Ligands of PPAR α, β/δ, γ, RAR, RXR and LXR on the Fatty Acid Composition of Phospholipids in Mice
Kathrin Weiss et al.
LIPIDS (2011)
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Jang Hyun Choi et al.
NATURE (2011)
DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex
Jun Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy
Maria D. Sanchez-Nino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production
Jiro Toyonaga et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Estrogen Receptor Alpha Expression in Podocytes Mediates Protection against Apoptosis In-Vitro and In-Vivo
Sebastian Kummer et al.
PLOS ONE (2011)
Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism
Xiaoxin X. Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Estrogens and Progression of Diabetic Kidney Damage
Sophie Doublier et al.
CURRENT DIABETES REVIEWS (2011)
Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
Pantelis A. Sarafidis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Nrf2-regulated PPARγ Expression Is Critical to Protection against Acute Lung Injury in Mice
Hye-Youn Cho et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Partial prevention of active Heymann nephritis by lα, 25 dihydroxyvitamin D3
D. D. BRANISTEANU et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Glucocorticoids' Pharmacology: Past, Present and Future
Stefania Gessi et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
Xiaoxin X. Wang et al.
DIABETES (2010)
Peroxisome Proliferator-Activated Receptor-γ Increases Adiponectin Secretion via Transcriptional Repression of Endoplasmic Reticulum Chaperone Protein ERp44
Qinqiang Long et al.
ENDOCRINOLOGY (2010)
The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3
J. Wesley Pike et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2010)
1,25-Dihydroxyvitamin D-3 Ameliorates Podocytopenia in Rats with Adriamycin-induced Nephropathy
Min-shu Zou et al.
INTERNAL MEDICINE (2010)
Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
David J. Graham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Mineralocorticoid Receptor Blockade Enhances the Antiproteinuric Effect of an Angiotensin II Blocker through Inhibiting Podocyte Injury in Type 2 Diabetic Rats
Akira Nishiyama et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: Promising new therapeutic targets?
Pit Sertznig et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Dick de Zeeuw et al.
LANCET (2010)
Phospholipase D2-Dependent Inhibition of the Nuclear Hormone Receptor PPARγ by Cyclic Phosphatidic Acid
Tamotsu Tsukahara et al.
MOLECULAR CELL (2010)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi et al.
NATURE (2010)
Nuclear hormone receptors in diabetic nephropathy
Xiaoxin X. Wang et al.
NATURE REVIEWS NEPHROLOGY (2010)
Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection
Hua-Feng Liu et al.
NEPHROLOGY (2010)
Coactivators in PPAR-Regulated Gene Expression
Navin Viswakarma et al.
PPAR RESEARCH (2010)
Dose- and time-dependent glucocorticoid receptor signaling in podocytes
Adam Guess et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Deletion of PPAR-gamma in immune cells enhances susceptibility to antiglomerular basement membrane disease
Cristen Chafin et al.
JOURNAL OF INFLAMMATION RESEARCH (2010)
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Christopher K. Glass et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Stretch reduces nephrin expression via an angiotensin II-AT1-dependent mechanism in human podocytes: effect of rosiglitazone
Ilaria Miceli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial
Steven Fishbane et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model
Sue Ellen Touma et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis
Sankar D. Navaneethan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Vitamin D, Proteinuria, Diabetic Nephropathy, and Progression of CKD
Rajiv Agarwal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury
Hai-Chun Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Uzma F. Mehdi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Glucocorticoid resistance in inflammatory diseases
Peter J. Barnes et al.
LANCET (2009)
Aldosterone Induces Apoptosis in Rat Podocytes: Role of PI3-K/Akt and p38MAPK Signaling Pathways
Cheng Chen et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2009)
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria
Xiaoxin X. Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Inducible rodent models of acquired podocyte diseases
Jeffrey W. Pippin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Retinoic acid synthesis and signaling during early organogenesis
Gregg Duester
CELL (2008)
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease - A randomized double-blind pilot trial
Pooneh Alborzi et al.
HYPERTENSION (2008)
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease
Christian A. Schneider et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Retinoic acid utilizes CREB and USF1 in a transcriptional feed-forward loop in order to stimulate MKP1 expression in human immunodeficiency virus-infected podocytes
Ting-Chi Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA
Vikas Chandra et al.
NATURE (2008)
Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease
Shigeru Shibata et al.
NATURE MEDICINE (2008)
Dexamethasone's prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation
Takehiko Wada et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2008)
Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms
Daniel S. Straus et al.
TRENDS IN IMMUNOLOGY (2007)
Separating transrepression and transactivation: A distressing divorce for the glucocorticoid receptor?
Robert Newton et al.
MOLECULAR PHARMACOLOGY (2007)
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy
Tao Jiang et al.
DIABETES (2007)
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia
Mark A. Deeg et al.
DIABETES CARE (2007)
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
Andrew Advani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
M. Amine Bouhlel et al.
CELL METABOLISM (2007)
PPARs and molecular mechanisms of transrepression
Mercedes Ricote et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
PPARγ in human and mouse physiology
Sami Heikkinen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Peroxisome proliferator-activated receptor α/γ dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice
Dae Ryong Cha et al.
DIABETES (2007)
Podocytes in culture: past, present, and future
S. J. Shankland et al.
KIDNEY INTERNATIONAL (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
PPAR-γ agonist protects podocytes from injury
T. Kanjanabuch et al.
KIDNEY INTERNATIONAL (2007)
A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A
Riki Kawaguchi et al.
SCIENCE (2007)
Podocyte as the target for aldosterone - Roles of oxidative stress and Sgk1
Shigeru Shibata et al.
HYPERTENSION (2007)
Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway
John Cijiang He et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors
Miki Nagase et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse
Anna C. Calkin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Angie L. Bookout et al.
CELL (2006)
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt et al.
KIDNEY INTERNATIONAL (2006)
Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms
Tatsuo Okada et al.
DIABETES (2006)
Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
X Sun et al.
DIABETOLOGIA (2006)
Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker
Miki Nagase et al.
HYPERTENSION (2006)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis
H-C Yang et al.
KIDNEY INTERNATIONAL (2006)
Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A
H Olsen et al.
EXPERIMENTAL CELL RESEARCH (2006)
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Sang-Youb Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins
CD Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Update on glucocorticoid action and resistance
K Ito et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Estrogen receptors and human disease
BJ Deroo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways
PJ Hughes et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma
T Tomaru et al.
ENDOCRINOLOGY (2006)
Combinatorial roles of nuclear receptors in inflammation and immunity
CK Glass et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Disruption of the lecithin: Retinol acyltransferase gene makes mice more susceptible to vitamin a deficiency
LM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization
RF Ransom et al.
KIDNEY INTERNATIONAL (2005)
Regression of existing glomerulosclerosis by inhibition of aldosterone
JC Aldigier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
G Pascual et al.
NATURE (2005)
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
S Ogawa et al.
CELL (2005)
Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: Role of p53 and Bcl-2-related family proteins
T Wada et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
A novel peroxisome proliferator-activated receptor γ isoform with dominant negative activity generated by alternative splicing
L Sabatino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo
MR Vaughan et al.
KIDNEY INTERNATIONAL (2005)
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis
MP Winn et al.
SCIENCE (2005)
The human glucocorticoid receptor: One gene, multiple proteins and diverse responses
JG Zhou et al.
STEROIDS (2005)
Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes
RF Ransom et al.
KIDNEY INTERNATIONAL (2005)
Gene expression profiling of NRF2-mediated protection against oxidative injury
HY Cho et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Expression and function of the human mineralocorticoid receptor:: lessons from transgenic mouse models
D Le Menuet et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation
Q Zhao et al.
LEUKEMIA (2004)
Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease
GP de Lema et al.
KIDNEY INTERNATIONAL (2004)
Retinoids in nephrology: Promises and pitfalls
Q Xu et al.
KIDNEY INTERNATIONAL (2004)
Effect of retinoic acid in experimental diabetic nephropathy
SY Han et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells
E Cañón et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice
M Tanimoto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Expression of peroxisome proliferator-activated receptor isoform proteins in the rat kidney
K Sato et al.
HYPERTENSION RESEARCH (2004)
Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model
XY Zhou et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells - Cross-talk between the cAMP and the retinoic acid signaling pathways
E Parrella et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The retinoic acid-responsive proline-rich protein is identified in promyeloleukemic HL-60 cells
T Inagaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Thiazolidinediones and blood lipids in type 2 diabetes
JPH van Wijk et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Retinoids as a potential treatment for experimental puromycin-induced nephrosis
V Moreno-Manzano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors:: Evidence for distinct molecular pathways in thyroid follicular carcinoma
MN Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Identification of an intracellular receptor for lysophosphatidic acid (LPA):: LPA is a transcellular PPARγ agonist
TM McIntyre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression regulation by retinoic acid
JE Balmer et al.
JOURNAL OF LIPID RESEARCH (2002)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Function and regulation of CREB family transcription factors in the nervous system
BE Lonze et al.
NEURON (2002)
Regulation of retinoic acid receptor α by protein kinase C in B16 mouse melanoma cells
G Boskovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter
M Benkoussa et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy
P Paueksakon et al.
KIDNEY INTERNATIONAL (2002)
cAMP pathway in podocytes
N Endlich et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
Retinoid receptor-specific agonists alleviate experimental glomerulonephritis
I Lehrke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor
JD Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Intervention by retinoic acid in oxidative stress-induced apoptosis
M Kitamura et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Vitamin A and kidney development
T Gilbert
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
M Schaier et al.
KIDNEY INTERNATIONAL (2001)
Retinoids, apoptosis and cancer
D Simoni et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis
C Dechow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2001)
Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria
T Nakamura et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis
K Makibayashi et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
LJ Ma et al.
KIDNEY INTERNATIONAL (2001)
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
G Chinetti et al.
INFLAMMATION RESEARCH (2000)
Recent developments in receptor-selective retinoids
S Nagpal et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR
YJ Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
